❓ A WA parliamentary question addresses concerns about a potential shortage of the Boostrix whooping cough vaccine and its effectiveness, receiving assurances from the Minister of Health.
AnsweredQoN 924Legislative Council
QuestionView source ↗
(1) Is there a shortage of whooping cough vaccine, called Boostrix, in Western Australia? (2) If yes to (1), what is the Department of Health doing about the shortage of whooping cough vaccine? (3) Is the three-way vaccine sufficient coverage against whooping cough? (4) If yes to (3), will the minister please provide a brief explanation of why the three-way vaccine provides sufficient coverage against whooping cough? Hon SUE ELLERY
AnswerView source ↗
I thank the member for some notice of this question. (1) No. (2) Not applicable. (3) Yes. (4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
(2) If yes to (1), what is the Department of Health doing about the shortage of whooping cough vaccine? (3) Is the three-way vaccine sufficient coverage against whooping cough? (4) If yes to (3), will the minister please provide a brief explanation of why the three-way vaccine provides sufficient coverage against whooping cough? Hon SUE ELLERY replied: I thank the member for some notice of this question. (1) No. (2) Not applicable. (3) Yes. (4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
(3) Is the three-way vaccine sufficient coverage against whooping cough? (4) If yes to (3), will the minister please provide a brief explanation of why the three-way vaccine provides sufficient coverage against whooping cough? Hon SUE ELLERY replied: I thank the member for some notice of this question. (1) No. (2) Not applicable. (3) Yes. (4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
(4) If yes to (3), will the minister please provide a brief explanation of why the three-way vaccine provides sufficient coverage against whooping cough? Hon SUE ELLERY replied: I thank the member for some notice of this question. (1) No. (2) Not applicable. (3) Yes. (4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
Hon SUE ELLERY replied: I thank the member for some notice of this question. (1) No. (2) Not applicable. (3) Yes. (4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
I thank the member for some notice of this question. (1) No. (2) Not applicable. (3) Yes. (4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
(1) No. (2) Not applicable. (3) Yes. (4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
(2) Not applicable. (3) Yes. (4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
(3) Yes. (4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
(4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
(2) If yes to (1), what is the Department of Health doing about the shortage of whooping cough vaccine? (3) Is the three-way vaccine sufficient coverage against whooping cough? (4) If yes to (3), will the minister please provide a brief explanation of why the three-way vaccine provides sufficient coverage against whooping cough? Hon SUE ELLERY replied: I thank the member for some notice of this question. (1) No. (2) Not applicable. (3) Yes. (4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
(3) Is the three-way vaccine sufficient coverage against whooping cough? (4) If yes to (3), will the minister please provide a brief explanation of why the three-way vaccine provides sufficient coverage against whooping cough? Hon SUE ELLERY replied: I thank the member for some notice of this question. (1) No. (2) Not applicable. (3) Yes. (4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
(4) If yes to (3), will the minister please provide a brief explanation of why the three-way vaccine provides sufficient coverage against whooping cough? Hon SUE ELLERY replied: I thank the member for some notice of this question. (1) No. (2) Not applicable. (3) Yes. (4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
Hon SUE ELLERY replied: I thank the member for some notice of this question. (1) No. (2) Not applicable. (3) Yes. (4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
I thank the member for some notice of this question. (1) No. (2) Not applicable. (3) Yes. (4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
(1) No. (2) Not applicable. (3) Yes. (4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
(2) Not applicable. (3) Yes. (4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
(3) Yes. (4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
(4) The new three-way booster vaccine, Boostrix, is the only available whooping cough vaccine licensed for persons over eight years of age. Although the degree and duration of protection against whooping cough from Boostrix is uncertain due to its newness, evidence from clinical trials indicates that it will provide more than 85 per cent protection against whooping cough for five to 10 years after vaccination.
Explore WA Government Data
Search the full archive in the free dashboard, or query programmatically via API.
Explore more
Government Gazette
Appointments, regulatory notices, planning changes.
Hansard
Debates, questions, speeches and sentiment.
Tabled Papers
Reports and documents tabled in Parliament.
Committees
Committee profiles and recent reports.
Regulations
Subsidiary legislation with filters and summaries.
Bills
Proposed laws and parliamentary progress.
Acts
Current WA legislation and summaries.
Explanatory Memoranda
Bills with EMs (text/PDF) available.
Members
MP profiles, party breakdown and rankings.
Pollie Rankings
Data-driven rankings across 19 categories.
Amendment Chains
Track how schemes and regulations evolve over time.